# Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma

> **NCT01903694** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 474 (estimated)

## Conditions studied

- Child-Pugh A Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sorafenib + Pravastatin
- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT01903694
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-11
- **Final completion:** —
- **Target enrollment:** 474 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01903694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01903694, "Randomized Trial Sorafenib-Pravastatin Versus Sorafenib Alone for the Palliative Treatment of Child-Pugh A Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT01903694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*